Protocolised reduction of non-resuscitation fluids versus usual care in patients with septic shock (REDUSE): a protocol for a multicentre feasibility trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
28 02 2023
Historique:
entrez: 28 2 2023
pubmed: 1 3 2023
medline: 3 3 2023
Statut: epublish

Résumé

Administration of large volumes of fluids is associated with poor outcome in septic shock. Recent data suggest that non-resuscitation fluids are the major source of fluids in the intensive care unit (ICU) patients suffering from septic shock. The present trial is designed to test the hypothesis that a protocol targeting this source of fluids can reduce fluid administration compared with usual care. The design will be a multicentre, randomised, feasibility trial. Adult patients admitted to ICUs with septic shock will be randomised within 12 hours of admission to receive non-resuscitation fluids either according to a restrictive protocol or to receive usual care. The healthcare providers involved in the care of participants will not be blinded. The participants, outcome assessors at the 6-month follow-up and statisticians will be blinded. Primary outcome will be litres of fluids administered within 3 days of randomisation. Secondary outcomes will be proportion of randomised participants with outcome data on all-cause mortality; days alive and free of mechanical ventilation within 90 days of inclusion; any acute kidney injury and ischaemic events in the ICU (cerebral, cardiac, intestinal or limb ischaemia); proportion of surviving randomised patients who were assessed by European Quality of Life 5-Dimensions 5-Level questionnaire and Montreal Cognitive Assessment; proportion of all eligible patients who were randomised and proportion of participants experiencing at least one protocol violation. Ethics approval has been obtained in Sweden. Results of the primary and secondary outcomes will be submitted for publication in a peer-reviewed journal. NCT05249088.

Identifiants

pubmed: 36854601
pii: bmjopen-2022-065392
doi: 10.1136/bmjopen-2022-065392
pmc: PMC9980317
doi:

Banques de données

ClinicalTrials.gov
['NCT05249088']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e065392

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

N Engl J Med. 2014 Oct 9;371(15):1381-91
pubmed: 25270275
Intensive Care Med. 2016 Nov;42(11):1695-1705
pubmed: 27686349
Crit Care. 2013 Feb 04;17(1):204
pubmed: 23394211
BMC Med Res Methodol. 2017 Dec 6;17(1):162
pubmed: 29207961
Eur J Anaesthesiol. 2016 Jul;33(7):475-82
pubmed: 27058509
Ann Intensive Care. 2019 Nov 27;9(1):132
pubmed: 31776712
Intensive Care Med. 2018 Apr;44(4):409-417
pubmed: 29589054
Intensive Care Med. 2021 Nov;47(11):1181-1247
pubmed: 34599691
Intensive Care Med Exp. 2017 Oct 26;5(1):50
pubmed: 29075932
Ann Am Thorac Soc. 2018 Sep;15(9):1108-1110
pubmed: 30168744
N Engl J Med. 2022 Jun 30;386(26):2459-2470
pubmed: 35709019
Chest. 2020 Jun;157(6):1478-1496
pubmed: 31982391
Crit Care Med. 2017 Mar;45(3):386-394
pubmed: 27922878
N Engl J Med. 2023 Feb 9;388(6):499-510
pubmed: 36688507
Chest. 2020 Oct;158(4):1431-1445
pubmed: 32353418
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Chest. 2015 Dec;148(6):1462-1469
pubmed: 26291900
Crit Care Med. 2011 Feb;39(2):259-65
pubmed: 20975548
Crit Care Med. 2018 Oct;46(10):1600-1607
pubmed: 29985214
J Neurotrauma. 2021 Sep 1;38(17):2435-2446
pubmed: 33740873
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J Neurotrauma. 1998 Aug;15(8):573-85
pubmed: 9726257
JAMA. 2019 Feb 19;321(7):654-664
pubmed: 30772908
BMJ Evid Based Med. 2021 Jun;26(3):121-126
pubmed: 31988195
Crit Care. 2022 Dec 1;26(1):372
pubmed: 36457089
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Crit Care. 2008;12(3):R74
pubmed: 18533029
Eur J Anaesthesiol. 2021 Jun 1;38(6):625-633
pubmed: 33074941
JAMA. 2016 Feb 23;315(8):775-87
pubmed: 26903336
Intensive Care Med. 2017 May;43(5):625-632
pubmed: 28130687
Crit Care Med. 2001 Dec;29(12):2299-302
pubmed: 11801830
N Engl J Med. 2012 Jul 12;367(2):124-34
pubmed: 22738085

Auteurs

Anja Lindén (A)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Helsingborg Hospital, Lund University, Helsingborg, Sweden anja.linden@gmail.com.

Jane Fisher (J)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Helsingborg Hospital, Lund University, Helsingborg, Sweden.

Gisela Lilja (G)

Department of Clinical Sciences Lund, Neurology, Skåne University Hospital, Lund University, Lund, Sweden.

Markus Harboe Olsen (MH)

Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Neuroanaesthesiology, The Neuroscience Centre, Copenhagen University Hospital, Kobenhavn, Denmark.

Fredrik Sjövall (F)

Intensive and Perioperative Care, Department of Clinical Sciences Lund, Skane University Hospital, Lund University, Malmö, Sweden.

Mårten Jungner (M)

Intensive and Perioperative Care, Department of Clinical Sciences Malmö, Skane University Hospital, Lund University, Malmö, Sweden.

Martin Spångfors (M)

Department of Anesthesiology and Intensive Care, Kristianstad Hospital, Central Hospital in Kristianstad, Kristianstad, Sweden.

Line Samuelsson (L)

Department of Anesthesiology and Intensive Care, Östersund Hospital, Ostersund, Sweden.

Jonatan Oras (J)

Department of Anesthesiology and Intensive Care Medicine, University of Gothenburg, Goteborg, Sweden.

Adam Linder (A)

Department of Clinical Sciences Lund, Neurology, Skåne University Hospital, Lund University, Lund, Sweden.

Johan Unden (J)

Department of Operation and Intensive Care, Halland Hospital Halmstad, Halmstad, Sweden.

T Kander (T)

Intensive and Perioperative Care, Department of Clinical Sciences Lund, Skane University Hospital, Lund University, Lund, Sweden.

Miklós Lipcsey (M)

Anesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Hedenstierna Laboratory, Department of Clinical Sciences, Uppsala University, Uppsala, Sweden.

Niklas Nielsen (N)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Helsingborg Hospital, Lund University, Helsingborg, Sweden.

Janus C Jakobsen (JC)

Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.

Peter Bentzer (P)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Helsingborg Hospital, Lund University, Helsingborg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH